Recombinant Follicle Stimulating Hormone Market, Global Outlook and Forecast 2022-2028

July 2024 | 70 pages | ID: RB63504DBC35EN
Market Monitor Global

Abstracts

Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the 'contaminants' seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.

This report contains market size and forecasts of Recombinant Follicle Stimulating Hormone in global, including the following market information:

Global Recombinant Follicle Stimulating Hormone Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Recombinant Follicle Stimulating Hormone Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five Recombinant Follicle Stimulating Hormone companies in 2021 (%)

The global Recombinant Follicle Stimulating Hormone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

75IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Follicle Stimulating Hormone include Merck Serono, MSD, Techwell, GenSci, Gedeon Richter and Teva, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Follicle Stimulating Hormone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Follicle Stimulating Hormone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Recombinant Follicle Stimulating Hormone Market Segment Percentages, by Type, 2021 (%)

• 75IU
• 150IU
• Others

Global Recombinant Follicle Stimulating Hormone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Recombinant Follicle Stimulating Hormone Market Segment Percentages, by Application, 2021 (%)

• Infertility Treatment
• Assisted Reproductive Technology

Global Recombinant Follicle Stimulating Hormone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Recombinant Follicle Stimulating Hormone Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Follicle Stimulating Hormone revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Recombinant Follicle Stimulating Hormone revenues share in global market, 2021 (%)

Key companies Recombinant Follicle Stimulating Hormone sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies Recombinant Follicle Stimulating Hormone sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck Serono
• MSD
• Techwell
• GenSci
• Gedeon Richter
• Teva

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant Follicle Stimulating Hormone Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant Follicle Stimulating Hormone Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT FOLLICLE STIMULATING HORMONE OVERALL MARKET SIZE

2.1 Global Recombinant Follicle Stimulating Hormone Market Size: 2021 VS 2028
2.2 Global Recombinant Follicle Stimulating Hormone Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Follicle Stimulating Hormone Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Recombinant Follicle Stimulating Hormone Players in Global Market
3.2 Top Global Recombinant Follicle Stimulating Hormone Companies Ranked by Revenue
3.3 Global Recombinant Follicle Stimulating Hormone Revenue by Companies
3.4 Global Recombinant Follicle Stimulating Hormone Sales by Companies
3.5 Global Recombinant Follicle Stimulating Hormone Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Follicle Stimulating Hormone Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Follicle Stimulating Hormone Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Follicle Stimulating Hormone Players in Global Market
  3.8.1 List of Global Tier 1 Recombinant Follicle Stimulating Hormone Companies
  3.8.2 List of Global Tier 2 and Tier 3 Recombinant Follicle Stimulating Hormone Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Recombinant Follicle Stimulating Hormone Market Size Markets, 2021 & 2028
  4.1.2 75IU
  4.1.3 150IU
  4.1.4 Others
4.2 By Type - Global Recombinant Follicle Stimulating Hormone Revenue & Forecasts
  4.2.1 By Type - Global Recombinant Follicle Stimulating Hormone Revenue, 2017-2022
  4.2.2 By Type - Global Recombinant Follicle Stimulating Hormone Revenue, 2023-2028
  4.2.3 By Type - Global Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Follicle Stimulating Hormone Sales & Forecasts
  4.3.1 By Type - Global Recombinant Follicle Stimulating Hormone Sales, 2017-2022
  4.3.2 By Type - Global Recombinant Follicle Stimulating Hormone Sales, 2023-2028
  4.3.3 By Type - Global Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Follicle Stimulating Hormone Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant Follicle Stimulating Hormone Market Size, 2021 & 2028
  5.1.2 Infertility Treatment
  5.1.3 Assisted Reproductive Technology
5.2 By Application - Global Recombinant Follicle Stimulating Hormone Revenue & Forecasts
  5.2.1 By Application - Global Recombinant Follicle Stimulating Hormone Revenue, 2017-2022
  5.2.2 By Application - Global Recombinant Follicle Stimulating Hormone Revenue, 2023-2028
  5.2.3 By Application - Global Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Follicle Stimulating Hormone Sales & Forecasts
  5.3.1 By Application - Global Recombinant Follicle Stimulating Hormone Sales, 2017-2022
  5.3.2 By Application - Global Recombinant Follicle Stimulating Hormone Sales, 2023-2028
  5.3.3 By Application - Global Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Follicle Stimulating Hormone Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant Follicle Stimulating Hormone Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Follicle Stimulating Hormone Revenue & Forecasts
  6.2.1 By Region - Global Recombinant Follicle Stimulating Hormone Revenue, 2017-2022
  6.2.2 By Region - Global Recombinant Follicle Stimulating Hormone Revenue, 2023-2028
  6.2.3 By Region - Global Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Follicle Stimulating Hormone Sales & Forecasts
  6.3.1 By Region - Global Recombinant Follicle Stimulating Hormone Sales, 2017-2022
  6.3.2 By Region - Global Recombinant Follicle Stimulating Hormone Sales, 2023-2028
  6.3.3 By Region - Global Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Recombinant Follicle Stimulating Hormone Revenue, 2017-2028
  6.4.2 By Country - North America Recombinant Follicle Stimulating Hormone Sales, 2017-2028
  6.4.3 US Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.4.4 Canada Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.4.5 Mexico Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Recombinant Follicle Stimulating Hormone Revenue, 2017-2028
  6.5.2 By Country - Europe Recombinant Follicle Stimulating Hormone Sales, 2017-2028
  6.5.3 Germany Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.5.4 France Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.5.5 U.K. Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.5.6 Italy Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.5.7 Russia Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.5.8 Nordic Countries Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.5.9 Benelux Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Recombinant Follicle Stimulating Hormone Revenue, 2017-2028
  6.6.2 By Region - Asia Recombinant Follicle Stimulating Hormone Sales, 2017-2028
  6.6.3 China Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.6.4 Japan Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.6.5 South Korea Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.6.6 Southeast Asia Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.6.7 India Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Recombinant Follicle Stimulating Hormone Revenue, 2017-2028
  6.7.2 By Country - South America Recombinant Follicle Stimulating Hormone Sales, 2017-2028
  6.7.3 Brazil Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.7.4 Argentina Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Recombinant Follicle Stimulating Hormone Sales, 2017-2028
  6.8.3 Turkey Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.8.4 Israel Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.8.5 Saudi Arabia Recombinant Follicle Stimulating Hormone Market Size, 2017-2028
  6.8.6 UAE Recombinant Follicle Stimulating Hormone Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Merck Serono
  7.1.1 Merck Serono Corporate Summary
  7.1.2 Merck Serono Business Overview
  7.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Major Product Offerings
  7.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Sales and Revenue in Global (2017-2022)
  7.1.5 Merck Serono Key News
7.2 MSD
  7.2.1 MSD Corporate Summary
  7.2.2 MSD Business Overview
  7.2.3 MSD Recombinant Follicle Stimulating Hormone Major Product Offerings
  7.2.4 MSD Recombinant Follicle Stimulating Hormone Sales and Revenue in Global (2017-2022)
  7.2.5 MSD Key News
7.3 Techwell
  7.3.1 Techwell Corporate Summary
  7.3.2 Techwell Business Overview
  7.3.3 Techwell Recombinant Follicle Stimulating Hormone Major Product Offerings
  7.3.4 Techwell Recombinant Follicle Stimulating Hormone Sales and Revenue in Global (2017-2022)
  7.3.5 Techwell Key News
7.4 GenSci
  7.4.1 GenSci Corporate Summary
  7.4.2 GenSci Business Overview
  7.4.3 GenSci Recombinant Follicle Stimulating Hormone Major Product Offerings
  7.4.4 GenSci Recombinant Follicle Stimulating Hormone Sales and Revenue in Global (2017-2022)
  7.4.5 GenSci Key News
7.5 Gedeon Richter
  7.5.1 Gedeon Richter Corporate Summary
  7.5.2 Gedeon Richter Business Overview
  7.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Major Product Offerings
  7.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales and Revenue in Global (2017-2022)
  7.5.5 Gedeon Richter Key News
7.6 Teva
  7.6.1 Teva Corporate Summary
  7.6.2 Teva Business Overview
  7.6.3 Teva Recombinant Follicle Stimulating Hormone Major Product Offerings
  7.6.4 Teva Recombinant Follicle Stimulating Hormone Sales and Revenue in Global (2017-2022)
  7.6.5 Teva Key News

8 GLOBAL RECOMBINANT FOLLICLE STIMULATING HORMONE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Recombinant Follicle Stimulating Hormone Production Capacity, 2017-2028
8.2 Recombinant Follicle Stimulating Hormone Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Follicle Stimulating Hormone Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 RECOMBINANT FOLLICLE STIMULATING HORMONE SUPPLY CHAIN ANALYSIS

10.1 Recombinant Follicle Stimulating Hormone Industry Value Chain
10.2 Recombinant Follicle Stimulating Hormone Upstream Market
10.3 Recombinant Follicle Stimulating Hormone Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Recombinant Follicle Stimulating Hormone Distributors and Sales Agents in Global

11 CONCLUSION


12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Recombinant Follicle Stimulating Hormone in Global Market
Table 2. Top Recombinant Follicle Stimulating Hormone Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Follicle Stimulating Hormone Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Follicle Stimulating Hormone Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Follicle Stimulating Hormone Sales by Companies, (K Doses), 2017-2022
Table 6. Global Recombinant Follicle Stimulating Hormone Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Follicle Stimulating Hormone Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Recombinant Follicle Stimulating Hormone Product Type
Table 9. List of Global Tier 1 Recombinant Follicle Stimulating Hormone Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Follicle Stimulating Hormone Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Follicle Stimulating Hormone Sales (K Doses), 2017-2022
Table 15. By Type - Global Recombinant Follicle Stimulating Hormone Sales (K Doses), 2023-2028
Table 16. By Application – Global Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Follicle Stimulating Hormone Sales (K Doses), 2017-2022
Table 20. By Application - Global Recombinant Follicle Stimulating Hormone Sales (K Doses), 2023-2028
Table 21. By Region – Global Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Follicle Stimulating Hormone Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Follicle Stimulating Hormone Sales (K Doses), 2017-2022
Table 25. By Region - Global Recombinant Follicle Stimulating Hormone Sales (K Doses), 2023-2028
Table 26. By Country - North America Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2017-2022
Table 29. By Country - North America Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2023-2028
Table 38. By Country - South America Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2017-2022
Table 41. By Country - South America Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Follicle Stimulating Hormone Sales, (K Doses), 2023-2028
Table 46. Merck Serono Corporate Summary
Table 47. Merck Serono Recombinant Follicle Stimulating Hormone Product Offerings
Table 48. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. MSD Corporate Summary
Table 50. MSD Recombinant Follicle Stimulating Hormone Product Offerings
Table 51. MSD Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Techwell Corporate Summary
Table 53. Techwell Recombinant Follicle Stimulating Hormone Product Offerings
Table 54. Techwell Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. GenSci Corporate Summary
Table 56. GenSci Recombinant Follicle Stimulating Hormone Product Offerings
Table 57. GenSci Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Gedeon Richter Corporate Summary
Table 59. Gedeon Richter Recombinant Follicle Stimulating Hormone Product Offerings
Table 60. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Teva Corporate Summary
Table 62. Teva Recombinant Follicle Stimulating Hormone Product Offerings
Table 63. Teva Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Recombinant Follicle Stimulating Hormone Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 65. Global Recombinant Follicle Stimulating Hormone Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Recombinant Follicle Stimulating Hormone Production by Region, 2017-2022 (K Doses)
Table 67. Global Recombinant Follicle Stimulating Hormone Production by Region, 2023-2028 (K Doses)
Table 68. Recombinant Follicle Stimulating Hormone Market Opportunities & Trends in Global Market
Table 69. Recombinant Follicle Stimulating Hormone Market Drivers in Global Market
Table 70. Recombinant Follicle Stimulating Hormone Market Restraints in Global Market
Table 71. Recombinant Follicle Stimulating Hormone Raw Materials
Table 72. Recombinant Follicle Stimulating Hormone Raw Materials Suppliers in Global Market
Table 73. Typical Recombinant Follicle Stimulating Hormone Downstream
Table 74. Recombinant Follicle Stimulating Hormone Downstream Clients in Global Market
Table 75. Recombinant Follicle Stimulating Hormone Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Follicle Stimulating Hormone Segment by Type
Figure 2. Recombinant Follicle Stimulating Hormone Segment by Application
Figure 3. Global Recombinant Follicle Stimulating Hormone Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Follicle Stimulating Hormone Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Follicle Stimulating Hormone Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Follicle Stimulating Hormone Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Follicle Stimulating Hormone Revenue in 2021
Figure 9. By Type - Global Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Follicle Stimulating Hormone Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Follicle Stimulating Hormone Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
Figure 19. US Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
Figure 33. China Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Follicle Stimulating Hormone Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Follicle Stimulating Hormone Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Recombinant Follicle Stimulating Hormone by Region, 2021 VS 2028
Figure 50. Recombinant Follicle Stimulating Hormone Industry Value Chain
Figure 51. Marketing Channels